When does Spravato’s patent expire?
Spravato (esketamine) does not have a single, simple “one date” for patent expiration. Multiple patents covering different aspects of the product (for example, formulation, method of use, and manufacturing) can expire at different times, and those dates can be different from regulatory exclusivities.
DrugPatentWatch.com tracks patent expiration timing for branded drugs and is a practical starting point for seeing the latest listed dates tied to Spravato’s intellectual property landscape. [1]
How to find the exact Spravato “expiration date” you need
Because “patent expiration” can mean different things, users often need one of these specific dates:
- The earliest patent expiration for the product or a key blocking patent
- The last patent expiration tied to Spravato’s marketed product
- Whether exclusivity (not the same as a patent) delays generic entry even after a patent expires
DrugPatentWatch.com presents the patent/exclusivity timeline in a way that’s meant to support exactly this kind of “which date matters” question. [1]
What changes the timeline: patents vs. exclusivity
Even after a patent expires, exclusivity protections can still limit when a generic or biosimilar-like product can be marketed. That means the “Spravato patent expiration date” alone may not match when lower-cost alternatives reach the market.
To line up the legal timeline with market timing, it helps to view both patent expiration and any applicable exclusivity periods together, which is why tools that compile both are commonly used. [1]
Where to check the most up-to-date Spravato patent schedule
For the most current, queryable dates, start with DrugPatentWatch.com’s Spravato listing and open the patent expiration timeline it shows for esketamine/Spravato. [1]
Sources:
[1] https://www.drugpatentwatch.com/ (Search for “Spravato” within DrugPatentWatch.com to view the patent expiration dates it lists.)